Biolake and Wuhan SFDA:
Regulator’s Perspectives of the Proliferative Bio-industry in Central China

Hosted by MIT CSSA and CABA

A Presentation and Panel Discussion from
武汉市食品药品监督管理局(Wuhan SFDA)
Saturday, August 28, 2010
9:00am – 12:00pm
E51-315 (same building as the Tang Center), MIT, 182 Memorial Drive, Cambridge, MA 02139

Wuhan, China:
Where history meets modern times; where east meets west, north meets south; where Yangtze River meets Central China Plain; where intellects meet entrepreneurs; where new businesses meet investment. Where pharmaceutical and biomedical industry meet regulators services.

CABA 2010 Pharmaceutical/Biologic/Medical Device
Regulatory Affairs Training program

The 2010 Pharmaceutical/Biologic/Medical Device Regulatory Affairs Training program is designed to focus on regulatory affairs in biotechnology, pharmaceuticals, medical device as well as drug development perspectives, commercialization, and post-marketing management.

The following is a list of topics included for the training program of 2010:
1.Regulatory Affairs in US Biotechnology/Pharmaceutical Industry and International Regulations, Basic cGMP & Case Studies.
2.The FDA’s Fundamental Functions: Creating and Enforcing New Regulatory Standards
3.The FDA Field Office: Roles, Responsibilities, and Agents for Change.
4.Drug Safety and Reporting, Off-label Use - Regulations from a Clinician’s Perspective. <